Prostate Cancer - Results from #25260

Prostate cancer screening among ethnically diverse first-degree relatives of prostate cancer cases - Abstract August 6, 2012

Dietary patterns differ between urban and rural older, long-term survivors of breast, prostate, and colorectal cancer and are associated with body mass index - Abstract August 6, 2012

Use of radionuclides in metastatic prostate cancer: Pain relief and beyond - Abstract August 6, 2012

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study - Abstract August 6, 2012

Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram - Abstract August 6, 2012

Blood and tissue nitric oxide and malondialdehyde are prognostic indicators of localized prostate cancer - Abstract August 6, 2012

Coffee consumption and prostate cancer risk: Further evidence for inverse relationship - Abstract August 4, 2012

The role of genetic markers in the management of prostate cancer - Abstract August 4, 2012

Safety and preliminary efficacy analysis of the mTOR inhibitor Ridaforolimus in patients with taxane-treated, castration-resistant prostate cancer - Abstract August 4, 2012

ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis - Abstract August 4, 2012

Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer - Abstract August 3, 2012

Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer - Abstract August 3, 2012

Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: Tamoxifen or radiotherapy? - Abstract August 3, 2012

A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment - Abstract August 3, 2012

Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Abstract August 3, 2012

Review of salvage therapy for biochemically recurrent prostate cancer: The role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy - Abstract August 3, 2012

Androgen deprivation therapy: Past, present and future - Abstract August 3, 2012

Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy - Abstract August 3, 2012

New developments in castrate-resistant prostate cancer - Abstract August 3, 2012

Drivers for change in the management of prostate cancer - Guidelines and new treatment techniques - Abstract August 3, 2012

Page 1264 of 1437